J.C. Angulo

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

Vik Khullar, G. Amarenco, J.C. Angulo et al. · European Urology · 2012 · 425 citations

Medicine, Pharmacology, Urology +14

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase <scp>III</scp> studies

V. Khullar, Philip E.V. van Kerrebroeck, Sender Herschorn et al. · International Journal of Clinical Practice · 2013 · 211 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.

David J. Grignon, Wael Sakr, Márta Tóth et al. · PubMed · 1996 · 191 citations

Medicine, Oncology, Pathology +17

Muscularis mucosa differentiates two populations with different prognosis in Stage T1 bladder cancer

J.C. Angulo, José I. López, David J. Grignon et al. · Urology · 1995 · 142 citations

Medicine, Oncology, Urology +14

Liver Transplantation Techniques for the Surgical Management of Renal Cell Carcinoma with Tumor Thrombus in the Inferior Vena Cava: Step-by-Step Description

Gaetano Ciancio, Javier González, Samir P. Shirodkar et al. · European Urology · 2010 · 128 citations

Medicine, Oncology, Surgery +16